Rezulin (REZ-u-lin, troglitazone), for Type II diabetes

    The FDA will soon approve Rezulin (REZ-u-lin, troglitazone), for Type II diabetes.

    It has the potential to be a significant advance.

    Troglitazone helps reduce insulin underlying metabolic defect in most patients with Type II diabetes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote